• Clozapine N-oxide (CNO): Enhancing Chemogenetic Assay Rigor

  2026-04-22

  This article provides scenario-based guidance for biomedical researchers using Clozapine N-oxide (CNO, SKU A3317) to address real-world assay challenges. It synthesizes evidence on CNO’s reliability, reproducibility, and role in chemogenetic and GPCR signaling research, equipping labs to optimize experimental outcomes and protocol consistency.

• Dissecting In Vitro Drug Response Metrics in Cancer Research

  2026-04-22

  Schwartz's dissertation critically evaluates the distinction between relative and fractional viability as in vitro readouts for anticancer drug assessment. The work demonstrates that growth inhibition and cell death are decoupled in many drug responses, offering new guidance for experimental design and interpretation of cytotoxicity data.

• PD 173074 in Cancer Research: From FGFR Inhibition to Assay

  2026-04-21

  PD 173074 enables precise, nanomolar-selective inhibition of FGFR1 and VEGFR2, powering reproducible angiogenesis and cancer pathway studies. This guide translates crystallographic and workflow innovations into actionable protocols, troubleshooting, and advanced applications for translational researchers.

• Trifluoperazine 2HCl: Mechanistic Insights and Protocols in

  2026-04-21

  Explore how Trifluoperazine 2HCl, a potent dopamine D2 receptor inhibitor, advances neuropharmacology and immunology research by uniquely bridging dopaminergic signaling and macrophage antibacterial activity. This article delivers practical assay guidance, deep mechanistic analysis, and a critical synthesis of the latest reference findings.

• Phosbind Biotin LC: Sequence-Independent Phosphorylation Det

  2026-04-20

  Phosbind Biotin LC addresses the challenge of detecting phosphorylated proteins on PVDF membranes in Western Blot workflows when phospho-specific antibodies are unavailable or insufficient. It offers a sequence-independent approach, but is unsuitable for aqueous-only protocols or long-term storage as a working solution.

• Advances in Combating Resistant Gram-Negative Infections

  2026-04-20

  The referenced study presents ceftolozane/tazobactam as a novel cephalosporin/β-lactamase inhibitor combination effective against multidrug-resistant gram-negative pathogens, particularly Pseudomonas aeruginosa and ESBL-producing Enterobacteriaceae. Its distinctive pharmacodynamics and clinical efficacy address critical gaps in the management of complicated intraabdominal and urinary tract infections.

• E-4031 in 3D Cardiac Organoid Electrophysiology: Precision &

  2026-04-19

  Explore how E-4031, a potent hERG potassium channel blocker, transforms 3D cardiac organoid electrophysiology research. This article delivers unique insight into optimizing assay design and interpreting proarrhythmic risk using advanced shell MEA platforms.

• Fenipentol (1-Phenyl-1-pentanol): Mechanisms, Evidence & Pro

  2026-04-18

  Fenipentol, also known as 1-Phenyl-1-pentanol, is a bioactive small molecule derived from Ligusticum chuanxiong and available from APExBIO. It acts as a choleretic agent and estrogen receptor alpha modulator, with established safety benchmarks and specificity in gastrointestinal and hepatobiliary research. This article details Fenipentol’s mechanistic action, usage parameters, and evidence base for advanced research applications.

• Substance P: Technical Guidance for CNS and Immune Research

  2026-04-17

  Substance P (SKU B6620) is a high-purity tachykinin neuropeptide used to investigate pain transmission, immune response, and neuroinflammation mechanisms. It is ideal for controlled in vitro studies requiring precise NK-1 receptor activation, but is not recommended for diagnostic, medical, or long-term storage applications.

• 3X (DYKDDDDK) Peptide: Precision Tool for FLAG-tagged Protei

  2026-04-16

  The 3X (DYKDDDDK) Peptide is a synthetic trimeric FLAG epitope tag widely used for the affinity purification and immunodetection of recombinant proteins. Its hydrophilic, compact structure enables high-sensitivity detection with minimal structural interference, making it integral in structural biology and protein engineering workflows.

• Machine Learning Prediction of Lipid Nanoparticles for mRNA

  2026-04-15

  This study introduces a machine learning framework, LightGBM, for predicting and optimizing lipid nanoparticle (LNP) formulations in mRNA vaccine delivery. By integrating computational modeling with experimental validation, the research accelerates ionizable lipid selection, including compounds such as SM-102, fundamentally advancing the development of efficient mRNA vaccine delivery systems.

• Cy3 Rabbit Anti-Goat IgG (H+L) Antibody: Technical Use Guide

  2026-04-14

  The Cy3 Rabbit Anti-Goat IgG (H+L) Antibody addresses the need for reliable, high-sensitivity detection of goat primary antibodies in immunofluorescence, IHC, ELISA, and flow cytometry. It should be used strictly for immunodetection workflows involving goat IgG primaries, as cross-reactivity and non-validated applications may produce unreliable results.

• Digoxin: Na+/K+ ATPase Pump Inhibitor for Cardiac & Antivira

  2026-04-13

  Digoxin is a well-characterized Na+/K+ ATPase pump inhibitor with validated efficacy in cardiac contractility modulation and dose-dependent inhibition of chikungunya virus infection in select human cell models. Its mechanistic specificity and high purity make it a cornerstone reagent for both arrhythmia and heart failure research. Cross-domain applications require careful attention to cell type and workflow context.

• Puromycin aminonucleoside: Precise Tool for Podocyte Injury

  2026-04-12

  Puromycin aminonucleoside is a validated nephrotoxic agent used to induce proteinuria and glomerular injury in animal models, enabling mechanistic studies of podocyte pathology. Its defined mechanism, reproducibility, and robust cytotoxicity benchmarks make it a gold-standard reagent for nephrotic syndrome research. APExBIO's product (A3740) provides detailed solubility data and optimized handling guidance for experimental rigor.

• Coumestrol as a Precision Tool for Ferroptosis and RA-FLS Mo

  2026-04-12

  Explore Coumestrol, a potent phytoestrogen estrogen receptor antagonist, as a precision research tool for dissecting ferroptosis and rheumatoid arthritis fibroblast signaling. This article uniquely bridges advanced nuclear receptor modulation with practical assay guidance for autoimmune disease studies.

16207 records 1/1081 page Next 12345 下5页 Last page